Inflammation Flashcards
78 – Prostacyclin (PGI\b2)
1: is synthesised by mast cells
2: mediates vascular spasm
3: is an antagonist of platelet aggregation
4: production is inhibited by aspirin
FFTT
Robbins 6th ed. Page: 70-71
1: produced by endothelial cells
2: potent vasodilation
23699 – Ferritin
1: is located in lysosomes
2: is visible by light microscopy in routine paraffin sections
3: is stored in mononuclear phagocytic cells
4: levels in serum reflect iron stores except in inflammation
TFTT
Robbins 5th ed. PAGE: 28-29; 610
14798 – Cytokines
1: act locally on immediately adjacent cells
2: have individual actions in modulating cell function which are specific for each cytokine
3: bind to non-specific receptors on target cells
4: are involved in stimulating cell growth but not cell differentiation
TFFF
Refer to Robbins, 6th Ed, Ch 7, page 191-192
15841 – Actions of the cytokines interleukin-1 (IL-1) and tumour necrosis factors (TNF alpha and beta) in defence reactions in the body, include
1: when released systemically, protecting against shock
2: enhancing leukocyte-endothelial adhesion in acute inflammation
3: activating fibroblast migration and collagen synthesis
4: influence on the hypothalamus resulting in fever
FTTT
IL-1/TNF is all pro-inflammation, pro-healing (including healing by fibroplasia). Hence, responses 2, 3 and 4 are all True (fibroplasia and collagen synthesis are stimulated). However, the vasoactive and prothrombocoagulant effects can be devastating when there is avid systemic release/activation of IL- 1/TNF systemically (as, for example in severe bacteraemia [septicaemia in non-Robbins terms]), when widespread vasodilatation and increased vascular permeability contribute to the syndrome of irreversible shock (and to DIC also).
23779 – Interleukin-1 (IL-1), secreted by cells of the mononuclearphagocyte system (MPS), has been demonstrated to have an important direct role in
1: inhibiting proliferation of T helper cells
2: endothelial cell activation
3: hypothalamus-mediated fever induction
4: enhancement of monocyte/macrophage bactericidal capacity
FTTF
Robbins 5th ed. Chapter: 3 Pages: 71, 174
15528 – Complement
1: may be activated in the absence of immune complexes
2: is important in the formation of granulomas
3: binds to the mast cell membrane and inhibits degranulation
4: kills target cells by triggering apoptosis
TFFF
Refer to Roitt, 9th Ed, page 11-14
8621 – Complement may play an important part in each of the following activities EXCEPT
A. increasing vascular permeability
B. phagocytosis of bacteria
C. release of histamine from mast cells
D. activation of fibrinolysis
E. destruction (killing) of bacteria
D
Robbins, 6th ed, Ch 3 and 5
15928 – S: Complement activation through the ‘bypass’ mechanism is of critical importance in early defence against infection by virulent pyogenic bacteria not previously encountered because R: some subgroups of immunoglobulin G (IgG) do not activate complement by the ‘classical’ pathway following reaction with specific (bacterial) antigen.
S is true, R is true but not a valid explanation of S
Complement activation is critical to a successful acute inflammatory reaction and to opsonisation of bacteria in the early phases of acute inflammation in immunologically ‘unprimed’ individuals. This must protect the person until infection is controlled by innate mechanisms or until an immune response is generated. Subgroup 4 of IgG does not (after reacting with specific Ag) activate complement; IgG2 is a poor complement activator. However, the phenomenon under discussion has nothing to do with subgroup IgG activation of complement - this important ‘bypass activation’ of complement takes place far earlier than the immunologic production of Ig capable of dealing with this ‘new’ bacterium and is the ‘stopgap’ protection, pending Ig release.
25324 – Effects of complement activation may include
1: opsonisation
2: lysis of bacteria
3: chemotaxis of neutrophils
4: haemolysis
TTTT
Roitt 9th Edition PAGE: 12-16 Robbins 5th ed. PAGE: 182-183
25978 – Activators which induce platelet aggregation include
1: thromboxane A2 (TxA2)
2: nitric oxide
3: thrombin
4: adenosine triphosphate ATP
TFTF
Robbins 6th Edition Page: 120-122
15923 – The following mediators are synthesised ‘on the spot’ and immediately released by injured/ stimulated cells
1: tissue thromboplastin
2: leukotriene B4 (LTB4)
3: Interleukin-2 (IL-2)
4: C3b opsinic factor
TTTF
Platelets (activated) and endothelial cells (injured), in particular, manufacture tissue thromboplastin. LTB4 is a product of the lipoxygenase pathway metabolism of arachidonic acid (from cell membrane phospholipid). IL-2 production is particularly the province of CD4+, TH2 cells in B cell ‘help’. Complement is, of course, a plasma protein system.
15918 – Chemicals activated during/following tissue injury which normally circulate as inactive plasma precursors include
1: platelet activating factor
2: major basic protein
3: C3b opsinic factor
4: plasmin
FFTT
Platelet activating factor is stored in granules within some cells and manufactured ‘on the spot, on demand’ by others. Major basic protein is a product of eosinophil leukocytes - very effective in destroying multicellular parasites (and also bystander host cells). Complement components are, of course, plasma components (though some components are present in some cells also). Plasmin is another ‘cascade’ enzyme systems - contact activated.
15994 – Fibroblasts proliferate and migrate during the healing process in response to the direct action of
1: cytokines
2: expression of adhesion molecules on endothelial cells
3: leukotrienes
4: platelet activating factor (PAF)
TFFF
Fibroblast proliferation and differentiation appears to be largely under the control of growth-promoting and growth-controlling cytokines. The influence of other factors such as extracellular matrix products (particularly fibronectin, laminin, etc and fibrino-peptides), although persuasive, is still equivocal. The endothelial adhesion molecules include members of the immunoglobulin family of proteins - they have no known influence on fibroblast ( or other ECM cell ) activity and the same goes for the two cell membrane phospholipid derivatives LT and PAF.
15886 – Chemical mediators which increase permeability of venules during the acute inflammatory reaction include
1: platelet activating factor (PAF)
2: gamma interferon
3: bradykinin
4: histamine
TFTT
Platelet activating factor is derived from cell membrane phospholipid by phospholipase (PLA2) action, but not via pathways of prostaglandin or HETE/leukotriene metabolism. In low concentrations, it is an extremely potent inducer of vasodilator and permeability, as well as other aspects of the inflammatory process. Bradykinin and histamine are also both ‘classic’ permeability factors. Gamma-interferon has no effect on endothelial cells (other cytokines may act indirectly through endothelium-activation in pavementing, thus aiding ‘leukocyte-mediated’ permeability - but not directly).
25980 – Increase in vascular permeability may account for the oedema in
1: acute anaphylaxis
2: adult respiratory distress syndrome
3: serum sickness
4: lymphoedema
TTTF
Robbins 5th Edition Page: 55&68 vs 180, 184&(677)
15881 – Arteriolar dilatation occurring in the early stages of acute inflammation, is mediated by
1: prostacyclin (PGI2)
2: nitric oxide (NO)
3: leukotriene B4 (LTB4)
4: neutrophil lysosomal enzymes
TTFF
Prostacyclin and nitric oxide are both powerful vasodilating agents, both produced by intact endothelium. Leukotriene B4 is produced from arachidonic acid through the lipoxygenase pathway; it has powerful chemotactic effects, but does not directly influence either vascular flow or permeability. Neutrophil lysosomal enzymes appear to have no effect on vasodilatation and, in any case, are not active in the zone until acute inflammation is well established.